Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Imbrium Therapeutics
Imbrium Therapeutics
Purdue subsidiary buys non-opioid pain prospect from PureHealth
Fierce Biotech
Wed, 08/11/21 - 12:19 pm
Purdue Pharma
non-opioid pain treatments
PureTech Health
Imbrium Therapeutics
Interstitial Cystitis
Imbrium initiates phase 2 study of IMB-115 in insomnia associated with alcohol cessation
Pharmaceutical Business Review
Wed, 06/26/19 - 10:33 am
Imbrium Therapeutics
clinical trials
IMB-115
insomnia
IAAC
Purdue Pharma’s newly created subsidiaries raise questions over attempts to shield assets from bankruptcy
Stat
Mon, 04/1/19 - 09:31 pm
Purdue Pharma
opioids
opioid crisis
Adlon Therapeutics
Imbrium Therapeutics
Imbrium Therapeutics and Mundipharma EDO Announce Orphan Drug Designation for Relapsed Refractory Biliary Tract Cancer Treatment
CP Wire
Fri, 02/22/19 - 10:00 am
Imbrium Therapeutics
Mundipharma EDO
Purdue Pharma
etoposide toniribate
cholangiocarcinoma
Imbrium Therapeutics and Mundipharma EDO Announce Orphan Drug Designation for Relapsed Refractory Biliary Tract Cancer Treatment
Fri, 02/22/19 - 09:59 am
Imbrium Therapeutics
Mundipharma EDO
Purdue Pharma
etoposide toniribate
cholangiocarcinoma
